The Friedreich Ataxia (FRDA) is a neurodegenerative disease caused by an abnormality in the gene that codes for a protein called frataxin. This disease mainly affects the central and peripheral nervous system and generally arises in the age of puberty, manifesting itself with ataxia of the limbs. In this work, we demonstrate how reactive oxygen species (ROS) scavenging quantum cluster of gold atoms improve the mitochondrial activity and function, thus reducing the oxidative damage in the patients affected by the FRDA.
Villa C; Legato, M; Umbach, A; Riganti, C; Jones, R; Martini, B; Boido, M; Medana, C; Facchinetti, I; Barni, D; Pinto, M; Arguello, T; Belicchi, M; Fagiolari, G; Liaci, C; Moggio, M; Ruffo, R; Moraes, C. T; Monguzzi, A; Merlo, G, R; Torrente, Y. Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia. SCIENCE TRANSLATIONAL MEDICINE 13, 607 (2021).